Ignite Creation Date:
2025-12-26 @ 11:10 AM
Ignite Modification Date:
2025-12-29 @ 7:22 AM
Study NCT ID:
NCT00675012
Status:
COMPLETED
Last Update Posted:
2014-05-30
First Post:
2008-05-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer
Sponsor:
AGC Biologics S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NGR005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None